Non Invasive Prenatal Testing (NIPT) Market by Instruments, Application & End User – 2021

The non-invasive prenatal testing (NIPT) market is expected to reach USD 2.88 Billion by 2021 from USD 1.35 Billion in 2016, at a CAGR of 16.4% from 2016 to 2021. The major factors driving the growth of this market include the growing preference for non-invasive techniques over invasive methods, rising focus on reimbursement for NIPT, … Continue reading Non Invasive Prenatal Testing (NIPT) Market by Instruments, Application & End User – 2021

Advertisements

The global glycomics market was USD 649.5 Million in 2016 | Dominated By North America

The key players in the glycomics market include Agilent Technologies (U.S.), Bruker Corporation (U.S.), Danaher Corporation (U.S.), New England Biolabs (U.S.), ProZyme, Inc. (U.S.), Shimadzu Corporation (Japan), Merck KGaA (Germany), Takara Bio, Inc. (Japan), Thermo Fisher Scientific (U.S.), and Waters Corporation (U.S.). Factors such as increasing government and private funding for glycomics and proteomics research and … Continue reading The global glycomics market was USD 649.5 Million in 2016 | Dominated By North America

The western blotting market was USD 574.8 Million in 2016, Expect High Growth

Bio-Rad Laboratories, Inc. (U.S.), Thermo Fisher Scientific, Inc. (U.S.), GE Healthcare (U.S.), Advansta, Inc. (U.S.), LI-COR Biosciences (U.S.), PerkinElmer, Inc. (U.S.), Bio-Techne Corporation (U.S.), Merck KGaA (Germany), F. Hoffmann-La Roche Ltd. (Switzerland), and Cell Signaling Technology, Inc. (U.S.) are some of the key players in the market worldwide. For More Information : http://www.marketsandmarkets.com/pdfdownload.asp?id=235810711 On the … Continue reading The western blotting market was USD 574.8 Million in 2016, Expect High Growth

The biologics safety testing market was valued at USD 2.75 Billion in 2017

The top four players in this market are Lonza Group LTD. (Switzerland), Charles River Laboratories (U.S.), Merck KGaA (Germany) and SGS SA (Switzerland) are. These companies have a broad product & service portfolio with comprehensive features and have a strong geographical presence. By region, the global biologics safety testing market is segmented into North America, … Continue reading The biologics safety testing market was valued at USD 2.75 Billion in 2017

The global high-content screening market estimated USD 557.1 Million in 2017

The major players in the market are GE Healthcare (U.S.), Danaher Corporation (U.S.), PerkinElmer, Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), and Becton, Dickinson and Company (U.S.). Some of the other leading players in this market include BioTek Instruments Inc. (U.S.), Bio-Rad Laboratories Inc. (U.S.), Tecan Group Ltd. (Switzerland), Yokogawa Electric Corporation (Japan), and Merck … Continue reading The global high-content screening market estimated USD 557.1 Million in 2017

PCR to Dominate the Molecular Diagnostic Technologies Market

The study also provides analytical framework to understand various factors that determine the purchase decision of PCR instruments by end users. These factors include sensitivity, consistent quality of data, high-throughput ability, multiplexing capability, price of instrument, ease of use, services and support, and brand of a system, among others. The purchase decision of PCR instrument … Continue reading PCR to Dominate the Molecular Diagnostic Technologies Market

Polymerase Chain Reaction – Comparative Analysis and End User Preference Study

The overall market for PCR technology market is expected to grow rapidly owing to the expansion of its application areas and increased accuracy and precision. Furthermore, specific technology segments of the PCR market, such as dPCR (real-time PCR) and qPCR (digital PCR), are witnessing higher market growth owing to their benefits such as real-time process … Continue reading Polymerase Chain Reaction – Comparative Analysis and End User Preference Study